The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) hosted at the University of Cambridge, with funding from The Mark Foundation for Cancer Research and the Cancer Research UK Cambridge Centre, aims to revolutionise cancer care by re-inventing the treatment pathway for patients.
You can find a full list of media coverage about MFICM on the News page
Article co-authored by Professor Jean Abraham published in Nature Communications
Article co-authored by CMDL Director, Shubha Anand was published recently.
Article “Angiogenic and immune predictors of neoadjuvant axitinib response in renal cell carcinoma with venous tumour thrombus” published in Nature Communications.
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.
